Scribd
Upload
80 views1 page

Pro32 SupraventricularTachycardia

This document provides information on the assessment and treatment of supraventricular tachycardia (SVT). It lists potential causes of SVT including medications, diet, drugs, and medical history. Signs and symptoms include a heart rate over 150 beats per minute with a QRS complex less than 0.12 seconds. Treatment involves vagal maneuvers, adenosine, calcium channel blockers, beta blockers, and synchronized cardioversion if unstable. Continuous monitoring and 12-lead ECG are recommended.

Uploaded by

Ronald Kendall
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
80 views1 page

Pro32 SupraventricularTachycardia

This document provides information on the assessment and treatment of supraventricular tachycardia (SVT). It lists potential causes of SVT including medications, diet, drugs, and medical history. Signs and symptoms include a heart rate over 150 beats per minute with a QRS complex less than 0.12 seconds. Treatment involves vagal maneuvers, adenosine, calcium channel blockers, beta blockers, and synchronized cardioversion if unstable. Continuous monitoring and 12-lead ECG are recommended.

Uploaded by

Ronald Kendall
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Supraventricular Tachycardia

History Medications (Aminophylline, Diet pills, Thyroid supplements, Decongestants, Digoxin) Diet (caffeine, chocolate) Drugs (nicotine, cocaine) Past medical history History of palpitations / heart racing Syncope / near syncope Signs and Symptoms HR > 150/Min QRS < .12 Sec (if QRS >.12 sec, go to V-Tach Protocol If history of WPW, go to VTach Protocol Dizziness, CP, SOB Potential presenting rhythm Atrial/Sinus tachycardia Atrial fibrillation / flutter Multifocal atrial tachycardia Differential Heart disease (WPW, Valvular) Sick sinus syndrome Myocardial infarction Electrolyte imbalance Exertion, Pain, Emotional stress Fever Hypoxia Hypovolemia or Anemia Drug effect / Overdose (see HX) Hyperthyroidism Pulmonary embolus

B I P M

Legend MR EMT EMT- I EMT- P


Medical Control B

Universal Patient Care Protocol

B I P M

IV Protocol

I Pre-arrest
(No palpable BP, Altered mental status)

Stable

12 Lead ECG

May attempt Valsalva's or other vagal maneuver initially and after each drug administration if indicated. Adenosine Consider Diltiazem or Beta-Blocker Notify Destination or Contact Medical Control

P P

Adenosine Consider Sedation Midazolam or Lorazepam or Diazepam Synchronized Cardioversion May Repeat as needed If rhythm changes Go to Appropriate Protocol

Medical Protocols

P P Consider Diltiazem or Beta-Blocker 12 Lead ECG Notify Destination or Contact Medical Control P B

Pearls Recommended Exam: Mental Status, Skin, Neck, Lung, Heart, Abdomen, Back, Extremities, Neuro If patient has history or 12 Lead ECG reveals Wolfe Parkinson White (WPW), DO NOT administer a Calcium Channel Blocker (e.g., Diltiazem) or Beta Blockers. Adenosine may not be effective in identifiable atrial flutter/fibrillation, yet is not harmful. Monitor for hypotension after administration of Calcium Channel Blocker or Beta Blockers. Monitor for respiratory depression and hypotension associated with Midazolam. Continuous pulse oximetry is required for all SVT Patients. Document all rhythm changes with monitor strips and obtain monitor strips with each therapeutic intervention.

Protocol 32
Any local EMS System changes to this document must follow the NC OEMS Protocol Change Policy and be approved by OEMS

2009

You might also like